SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001485003-21-000018
Filing Date
2021-02-16
Accepted
2021-02-16 07:04:03
Documents
18
Period of Report
2021-02-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sesn-20210216.htm   iXBRL 8-K 39877
2 EX-99.1 blaacceptancefinalforrel.htm EX-99.1 10642
8 GRAPHIC blaacceptancefinalforrel001.jpg GRAPHIC 269581
9 GRAPHIC blaacceptancefinalforrel002.jpg GRAPHIC 305801
10 GRAPHIC blaacceptancefinalforrel003.jpg GRAPHIC 193163
  Complete submission text file 0001485003-21-000018.txt   1260447

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sesn-20210216.xsd EX-101.SCH 2423
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sesn-20210216_cal.xml EX-101.CAL 710
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sesn-20210216_def.xml EX-101.DEF 1643
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sesn-20210216_lab.xml EX-101.LAB 24993
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sesn-20210216_pre.xml EX-101.PRE 13190
11 EXTRACTED XBRL INSTANCE DOCUMENT sesn-20210216_htm.xml XML 11728
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 21632317
SIC: 2834 Pharmaceutical Preparations